Alopecia News and Research

RSS
Alopecia is the lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.
Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Reducing hair loss during chemotherapy: an interview with Richard Paxman

Reducing hair loss during chemotherapy: an interview with Richard Paxman

Cobimetinib with vemurafenib may have added benefit in melanoma with BRAF V600 mutation

Cobimetinib with vemurafenib may have added benefit in melanoma with BRAF V600 mutation

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

Paxman wins ‘Partnership with Academia Award’ for improving patient care with Huddersfield University

Paxman wins ‘Partnership with Academia Award’ for improving patient care with Huddersfield University

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

Combining medications may increase HBsAg loss in HBV patients

Combining medications may increase HBsAg loss in HBV patients

Heightened levels of psychological stress associated with skin complaints in college students

Heightened levels of psychological stress associated with skin complaints in college students

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

Inhibiting JAK family of enzymes promotes rapid hair growth, new study finds

Inhibiting JAK family of enzymes promotes rapid hair growth, new study finds

RXI-109 use after scar revision surgery has beneficial effect on suppression of hypertrophic scarring

RXI-109 use after scar revision surgery has beneficial effect on suppression of hypertrophic scarring

Paxman unveils commitment to ‘chase zero hair loss during chemotherapy’ at 2015 European Cancer Congress

Paxman unveils commitment to ‘chase zero hair loss during chemotherapy’ at 2015 European Cancer Congress

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Arsenic trioxide feasible in low-, high-risk acute promyelocytic leukaemia

Arsenic trioxide feasible in low-, high-risk acute promyelocytic leukaemia